Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jun-Jul;47(6):388-9.
doi: 10.1016/j.aprim.2014.07.011. Epub 2014 Nov 15.

[Considerations for ezetimibe and renal impairment]

[Article in Spanish]
Vicente Pallarés-Carratalá  1 , Belén Vizcaíno-Castillo  2 , José Luis Górriz-Teruel  3
Affiliations
Comment

[Considerations for ezetimibe and renal impairment]

[Article in Spanish]
Vicente Pallarés-Carratalá et al. Aten Primaria. 2015 Jun-Jul.
No abstract available

PubMed Disclaimer

Comment in

  • [Author's reply].
    Fernández-Liz E, Ortí Segarra C, Garrido Mesas I. Fernández-Liz E, et al. Aten Primaria. 2015 Jun-Jul;47(6):389-91. doi: 10.1016/j.aprim.2014.09.006. Epub 2014 Nov 14. Aten Primaria. 2015. PMID: 25454851 Free PMC article. Spanish. No abstract available.
  • [Development of the "Consensus guidelines for the use of drugs in renal failure"].
    March Pujol MA, Vía Sosa MÀ, Travé Mercadé P, Martínez-Castelao A. March Pujol MA, et al. Aten Primaria. 2017 Nov;49(9):558-560. doi: 10.1016/j.aprim.2016.12.006. Epub 2017 Apr 10. Aten Primaria. 2017. PMID: 28408117 Free PMC article. Spanish. No abstract available.

Comment on

References

    1. Fernández-Liz E., Ortí Segarra C., Garrido Mesas I. Ezetimiba asociada a simvastatina incrementa el riesgo de insuficiencia renal. Aten Primaria. 2014;46:451–452. - PMC - PubMed
    1. WHO Collaborating Centre for International Drug Monitoring [sitio web]. The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment [consultado 7 Jul 2014]. Disponible en: http://www.who-umc.org
    1. Górriz Teruel J.L., Beltrán Catalán S. Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes. Rev Esp Cardiol. 2012;65:586–587. - PubMed
    1. KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease. Kidney Int. 2013;(Suppl 3):262–305.
    1. Baigent C., Landray M.J., Reith C., Emberson J., Wheeler D.C., Tomson C. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet. 2011;377:2181–2192. - PMC - PubMed